Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 97767
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.97767
Figure 3
Figure 3 According to the artificial neural network model, the patient training and validation sets are divided into two risk layers as follows: High and low through Kaplan–Meier method. A: The Kaplan–Meier (KM) curve for the risk of the occurrence of portal vein thrombosis (PVT) through the artificial neural network (ANN) model within three years in the training group; B: The KM curve for the risk of the occurrence of PVT through the ANN model within five years in the training group; C: The KM curve for the risk of the occurrence of PVT through the ANN model within three years in the validation group; D: The KM curve for the risk of the occurrence of PVT through the ANN model within five years in the validation group.